Public Health Interventions Cost Effectiveness Database (PHICED)

Introduction

The Public Health Interventions Cost Effectiveness Database (PHICED) is a database of bibliographic records related to public health areas. It includes cost-effectiveness studies, NICE guidance and decision tools relating to alcohol, obesity, physical activity and tobacco. It is aimed at professionals who provide or commission public health interventions.

The development of this tool was funded by Health England and forms part of the National Library for Public Health.

Further information

• Find out about the methods used to produce PHICED.

Contact details

Please contact Sue Baughan if you have any feedback or comments about PHICED.

Results

Now showing 5 per page. On this page 56 to 60

Showing all records

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 

Intervention	Reference	PH Area	Patient Group	Country
Secondary prevention	Palmer AJ, Sendi PP, Spinas GA. Applying some UK Prospective Diabetes Study results to Switzerland: the cost-effectiveness of intensive glycaemic control with metformin versus conventional control in overweight patients with type-2 diabetes. Schweizerische Medizinische Wochenschrift. 2000;130(27-28):1034-40.	Obesity	Adults, People with Diabetes	Europe (not UK)
Secondary prevention	Cooney RN, Bryant P, Haluck R, Rodgers M, Lowery M. The impact of a clinical pathway for gastric bypass surgery on resource utilization. Journal of Surgical Research. 2001;98(2):97-101.	Obesity	Adults	USA
Secondary prevention	Lamotte M, Annemans L, Lefever A, Nechelput M, Masure J. A health economic model to assess the long-term effects and cost-effectiveness of orlistat in obese type 2 diabetic patients. Diabetes Care. 2002;25(2):303-8.	Obesity	Adults, People with Diabetes	Europe (not UK)
Primary Prevention	Trento M, Passera P, Bajardi M, Tomalino M, Grassi G, Borgo E, et al. Lifestyle intervention by group care prevents deterioration of Type II diabetes: a 4-year randomized controlled clinical trial. Diabetologia. 2002;45(9):1231-9.	Obesity, Physical Activity	Adults, People with Diabetes	Europe (not UK)
Secondary prevention	Maetzel A, Ruof J, Covington M, Wolf A. Economic evaluation of orlistat in overweight and obese patients with type 2 diabetes mellitus. Pharmacoeconomics. 2003;21(7):501-12.	Obesity	Adults, People with Diabetes	USA
Show  5102050   per page

Updated September 2011, based on searches undertaken on 24th August 2011